{"id":"W2601261230","doi":"10.1200/jco.2013.31.15_suppl.5059","title":"Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Prostate cancer; Abiraterone acetate; Taxane; Docetaxel; Discontinuation; Adverse effect; Surgery; Cancer; Breast cancer; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03496698,0.001463306,0.001227951,0.0007958239,0.001355396,0.002001747,0.001554143,0.002685338,0.01225469],"category_scores_gemma":[0.02543608,0.0007910154,0.002010995,0.001146403,0.001093482,0.001234262,0.001270964,0.003099949,0.003857128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001474538,"about_ca_system_score_gemma":0.006996434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003665018,"about_ca_topic_score_gemma":0.0009746482,"domain_scores_codex":[0.9798552,0.01645133,0.001241007,0.0007365626,0.0009881859,0.000727694],"domain_scores_gemma":[0.9779653,0.00720902,0.005573035,0.003643684,0.003460084,0.002148915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7544616,0.01436036,0.01704303,0.003448237,0.001770318,0.0006340211,0.0006936093,0.004018457,0.0111625,0.002018488,0.05632101,0.1340683],"study_design_scores_gemma":[0.4479288,0.3017047,0.0714881,0.001266718,0.002286623,0.001669947,0.0003504142,0.005853373,0.01689722,0.004029853,0.1463767,0.0001477231],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"empirical","genre_scores_codex":[0.3493702,0.004088643,0.03407292,0.00414181,0.001137249,0.4811963,0.06199754,0.001371881,0.06262341],"genre_scores_gemma":[0.5124356,0.001190681,0.02866798,0.004469275,0.0005134796,0.4117767,0.03354376,0.000248899,0.007153722],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03496698,"threshold_uncertainty_score":0.1849253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.100321079095189,"score_gpt":0.4946251942747958,"score_spread":0.3943041151796068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}